Smith & Nephew pulls the trigger on planned CFO succession | Personnel Moves

Smith & Nephew (NYSE:SNN) said last week that CFO Julie Brown left the orthopedics & wound care company, after announcing her succession last July.

Brown was named finance chief in November 2012 and assumed the role in February the following year. She is moving on to work as chief operating & financial officer for British luxury brand Burberry.

“Julie has made a significant contribution to the transformation of Smith & Nephew over the last 3½ years, building and embedding stronger finance capabilities across the company. The group optimization program has driven greater efficiency and her capital allocation framework has effectively and transparently prioritized the use of cash. I would like to thank her on behalf of the company, and personally for her valuable support and insight. We wish her well in the next stage of her career,” Smith & Nephew CEO Olivier Bohuon said in prepared remarks last year.

“I am immensely proud of my time at Smith & Nephew and what we have achieved together. We have made significant progress with group optimization and the finance transformation and delivered significant shareholder value. I look forward to joining the board of Burberry and pursuing a new opportunity in my career. It has been an honor to work with Olivier, from whom I have learned a great deal, and I wish him and everyone at Smith & Nephew all the best for the future,” Brown added.

 Fresenius NA moves Valle into the corner office
Fresenius Medical Care said that William Valle, who has served as exec VP of its North America dialysis service business since 2014, will be named the CEO of its North America business. Valle succeeds Ronald Kuerbitz, who is joining Agilon Health as CEO.
Read more

 SurgaColl appoints Allen as CEO
SurgaColl named William Allen to its corner office. Allen has previously served in general management and leadership roles at Smith & Nephew, Stryker and Angiodynamics, the company said.
Read more

 Merrimack taps Sanofi exec as pres, CEO
Merrimack Pharmaceuticals named Dr. Richard Peters as its president & CEO and said that the industry vet will also join the company’s board of directors. He has worked as senior VP & head of global rare diseases at Sanofi Genzyme and will succeed Gary Crocker.
Read more

 IsoRay CFO bows out

IsoRay Inc. said that its chief financial officer, Brien Ragle, resigned from his position at the company. The board of directors appointed Matthew Branson, the company’s Controller, as its principal financial officer until IsoRay names a new CFO.
Read more

• Biolase CFO, senior VP resigns
• Apollo Endosurgery names gastroenterologist as CMO
• Presbia CTO steps down
• Hologic names EMEA & Canada prez
• Endologix sales VP quits

The post Smith & Nephew pulls the trigger on planned CFO succession | Personnel Moves appeared first on MassDevice.

from MassDevice http://ift.tt/2iT0bL2